Address And Details

Two Intl Place, Suite 1400 , Boston, MA 02110
Fund Manager Samantha Pandolfi
Manager Tenure 5 Years 3 Months

Strategy And Objective

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Net Asset Value

as of 4:43 PM ET 10/15/2021

Performance

  • 1 Week
  • +1.24%
  • 1 Month
  • -1.54%
  • 3 Months
  • +2.01%
  • 1 Yr Return
  • +10.37%
  • 5 Yr Return
  • +37.93%

Equity Sector Breakdown

Health 51.07%
Finance 12.57%
IndustrialCyclical 8.40%
Services 8.31%
Technology 7.73%
ConsumerDurables 0.58%
Energy n/a
NonDurables n/a
RetailTrade n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 99.47%
ForeignStocks 27.67%
Convertible 0.27%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 799.04 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.56 0.12 2.32
Beta 0.69 0.72 0.76
R Squared 0.73 0.64 0.53
Std Deviation 15.17 13.73 13.88
Sharpe Ratio 0.86 0.88 n/a

Purchase Information

as of 5:33 PM ET 10/14/2021
Minimum Initial $1000
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 09/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 09/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +17.27%
  • +17.27%
+17.27% +17.27%
3 Year
  • +12.91%
  • +12.91%
+12.91% +12.91%
10 Year
  • +14.82%
  • +14.82%
+14.82% +14.82%
Life Of Fund
  • +13.41%
  • +13.41%
+13.41% +13.41%

Top 10 Holdings

Symbol Company Name % Of Assets
JNJ JOHNSON & JOHNSON 8.06%
UNH UNITEDHEALTH GROUP INC 7.34%
ABBV ABBVIE INC 4.49%
ROG ROCHE HOLDING AG 4.01%
LLY ELI LILLY & CO 3.92%
MDT MEDTRONIC PLC 3.83%
SASY.PA SANOFI 3.78%
TMO THERMO FISHER SCIENTIFIC INC 3.63%
AZN ASTRAZENECA PLC 3.56%
MRK MERCK & CO INC 3.22%

LATEST NEWS

Recent Articles from TheStreet

Nucor Lead

Cramer: Now Is Not the Time to Sell Nucor Steel Stock

Upside remains for steelmaker even after key downgrade, as infrastructure spending is still in play in Washington.

Levi Strauss Lead

Levi Strauss Bullish on Next-Gen Retail

The direct-to-consumer stores focus on local personalization, customization and digitalization.

Wall Street Lead

Cramer's Mad Money Recap: J&J, Netflix, Nvidia, Tesla

Cramer says the clouds over Wall Street may have broken. Get ready for next week's earnings parade.

Here Is What Jim Cramer Expects From Schlumberger's Earnings

Energy Stocks Emerge as Leaders: Curran

Years of underperformance appear over for hard-hit oil and gas stocks.

Dave Chappelle Netflix Lead

Netflix Employee Reportedly Laid Off Over Chappelle Show Leak

Internal unrest over content of comedian's latest program continues at streaming giant.

crypto copy

Stablecoin Issuer Tether Agrees to $41 Million Settlement with CTFC

Tether made 'untrue or misleading statements and omissions in connection with the U.S. dollar tether token stablecoin,' the CFTC said.

Boeing Invests $20 Million in Human Spaceflight Company Virgin Galactic

Virgin Galactic Could Fall Another 15%. Chart Shows Where to Buy Dip.

Virgin Galactic stock had verged on a breakout. Now it's dropping. Here's where we're looking to buy the dip.

The logo of Taiwan Semiconductor Manufacturing Co (TSMC) is pictured at its headquarters, in Hsinchu, Taiwan, Jan. 19, 2021. Photo: Reuters

Guilfoyle on the Biggest Threat to Taiwan Semiconductor

Chip foundry makes Taiwan an even bigger target for Beijing's aggressive moves.

Johnson & Johnson's vaccine Lead

Johnson & Johnson Covid Booster Backed by FDA Panel

Johnson & Johnson shares rose after an FDA advisory panel backed the authorization of boosters for the company's single-shot Covid-19 vaccine.

Moderna

Moderna Stock Slips as FDA Reportedly Delays Vaccine for Adolescents

Moderna shares slip on a report the FDA is delaying a decision to approve the company's COVID-19 vaccine for adolescents.